Guillain-Barré syndrome.
Lo
Y L
YL
D001323:Autoantibodies / Q000276:immunology*; D005732:Gangliosides / Q000276:immunology*; D020275:Guillain-Barre Syndrome / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D009469:Neuromuscular Junction / Q000276:immunology / Q000503:physiopathology; D010525:Peripheral Nerves / Q000187:drug effects / Q000276:immunology* / Q000503:physiopathology
D001323:Autoantibodies; D005732:Gangliosides; D007155:Immunologic Factors; C039129:GQ1b ganglioside